Primary Cells

T5426 Human Primary DF508/621+1G>T Cystic Fibrosis Bronchial Epithelial Cells

T5426 Human Primary DF508/621+1G&gt;T CF Bronchial Epithelial Cells by ABM — compound heterozygous CFTR (class II missense + class I splice site), 5×10⁵ cells/1.0 ml, BSL-II. PriCoat™ T25 Flasks and PriGrow TM5426 required. For CF drug discovery research. MTA required.

T5427 Human Primary DF508/S549N Cystic Fibrosis Bronchial Epithelial Cells

T5427 Human Primary DF508/S549N CF Bronchial Epithelial Cells by ABM — compound heterozygous CFTR (class II misfolding + class III gating), 5×10⁵ cells/1.0 ml, BSL-II. PriCoat™ T25 Flasks and PriGrow TM5427 required. For CFTR corrector + potentiator combination research. MTA required.

T5428 Human Primary COPD Lung Parenchymal Fibroblasts

T5429 Human Primary COPD Bronchial Epithelial Cells

T5429 Human Primary COPD Bronchial Epithelial Cells by ABM — COPD donor bronchial epithelium, 5×10⁵ cells/1.0 ml, BSL-II. Trypsin-sensitive; use Gentle Dissociation Solution (TM080). PriGrow III + 10% heat-inactivated FBS required. Dual cryopreservation. MTA required.

T5430 Human Primary Liver Sinusoidal Microvascular Endothelial Cells

T5430 Human Primary Liver Sinusoidal Microvascular Endothelial Cells by ABM — CD31/VE-Cadherin positive; cobblestone; 5×10⁵ cells/1.0 ml, BSL-II. Max 2 passages, 1:2 split; media every 3 days. Gelatin-coated PriCoat™ T25 Flasks + Human Endothelial Growth Medium (TM104) required. MTA required.

T5439 Human Primary Intestinal Mesenteric Vascular Endothelial Cells

T5439 Human Primary Intestinal Mesenteric Vascular Endothelial Cells by ABM — CD31 and VE-Cadherin positive, cobblestone; 5×10⁵ cells/1.0 ml, BSL-II. Max 2 passages, 1:2 split; media every 3 days. Gelatin-coated PriCoat™ T25 Flasks + Human Endothelial Growth Medium (TM104) required. MTA required.

T5440 Human Primary Mammary Microvascular Endothelial Cells

T5442 Human Primary Friedriech's Ataxia (FA) Fibroblast Cell Line 130

T5442 Human Primary Friedreich's Ataxia Fibroblast Cell Line 130 by ABM — late-onset FA patient (male, age 56, onset 41; GAA alleles 136/540 — lowest GAA burden in MBP FA panel), 5×10⁵ cells/1.0 ml, BSL-II. Seeding 10,000 cells/cm²; PriGrow III + 15% FBS + NEAA. Dual cryopreservation. MTA required.

T5444 Human Primary Friedriech's Ataxia (FA) Fibroblast Cell Line 6237

T5446 Human Primary Friedriech's Ataxia (FA) Fibroblast Cell Line 281

T5446 Human Primary Friedreich's Ataxia Fibroblast Cell Line 281 by ABM — FA patient (male, age 19, onset age 11; GAA alleles 630/806), 5×10⁵ cells/1.0 ml, BSL-II. Seeding 10,000 cells/cm²; PriGrow III + 15% FBS + NEAA required. Dual cryopreservation. MTA required.

T5448 Human Primary Friedriech's Ataxia (FA) Fibroblast Cell Line 4090

T5448 Human Primary Friedreich's Ataxia Fibroblast Cell Line 4090 by ABM — FA patient (female, age 21, onset age 12; GAA alleles 541/783), 5×10⁵ cells/1.0 ml, BSL-II. Seeding 10,000 cells/cm²; PriGrow III + 15% FBS + NEAA required. Dual cryopreservation. MTA required.

T5449 Human Primary Placental Microvascular Endothelial Cells

T5449 Human Primary Placental Microvascular Endothelial Cells by ABM — CD31 and VE-Cadherin positive, cobblestone; 5×10⁵ cells/1.0 ml, BSL-II. Max 2 passages, 1:2 split; media every 3 days. Gelatin-coated PriCoat™ T25 Flasks + Human Endothelial Growth Medium (TM104) required. MTA required.